Have a personal or library account? Click to login
SPP1 is a biomarker of cervical cancer prognosis and involved in immune infiltration Cover

SPP1 is a biomarker of cervical cancer prognosis and involved in immune infiltration

Revista Romana de Medicina de Laborator
Volume 30 (2022): Issue 3 (July 2022)
By: Qian Guo,  Wei He,  Dan Nie,  Wuzhi Li and  Ping Zhan  
Open Access
|Jul 2022

Authors

Qian Guo

Affiliated Hospital of Southwest Medical University, Sichuan Provincial Center for Gynaecology & Breast Disease: Gynaecology, China

Wei He

Affiliated Hospital of Southwest Medical University, Sichuan Provincial Center for Gynaecology & Breast Disease: Gynaecology, China

Dan Nie

Affiliated Hospital of Southwest Medical University, Sichuan Provincial Center for Gynaecology & Breast Disease: Gynaecology, China

Wuzhi Li

Affiliated Hospital of Southwest Medical University, Sichuan Provincial Center for Gynaecology & Breast Disease: Gynaecology, China

Ping Zhan

ping.zhan@gmx.net

Affiliated Hospital of Southwest Medical University, Sichuan Provincial Center for Gynaecology & Breast Disease: Gynaecology, China
DOI: https://doi.org/10.2478/rrlm-2022-0028 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 281 - 292
Submitted on: Jan 23, 2022
|
Accepted on: Jun 3, 2022
|
Published on: Jul 18, 2022
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
bioinformatics analysis,
SPP1,
tumour infiltrating lymphocytes,
cervical cancer
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2022 Qian Guo, Wei He, Dan Nie, Wuzhi Li, Ping Zhan, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 30 (2022): Issue 3 (July 2022)Next article